US 12018259
Treatment of liver diseases with cell death inducing DFFA like effector B (CIDEB) inhibitors
granted A61KA61K31/7088A61K38/465
Quick answer
US patent 12018259 (Treatment of liver diseases with cell death inducing DFFA like effector B (CIDEB) inhibitors) held by REGENERON PHARMACEUTICALS, INC. expires Mon Jun 20 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- REGENERON PHARMACEUTICALS, INC.
- Grant date
- Tue Jun 25 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jun 20 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 22
- CPC classes
- A61K, A61K31/7088, A61K38/465, A61P, A61P1/16